Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ferndale Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of innovative products for dermatology and aesthetic medicine. As a key member of the Ferndale Pharma Group, the company provides a diverse range of prescription and over-the-counter solutions, including topical anesthetics, skin repair treatments, and photoprotection supplements. Their portfolio is anchored by well-known brands such as LMX4 and Heliocare, which address both clinical skin conditions and cosmetic concerns. The company maintains a strong international presence with primary operations in the United States and the United Kingdom. Ferndale is recognized for its expertise in topical drug delivery and its commitment to evidence-based skin health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ferndale Pharmaceuticals.